Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer

被引:18
|
作者
Verstegen, Naomi E. [1 ]
Maat, Alexander P. W. M. [2 ]
Lagerwaard, Frank J. [1 ]
Paul, Marinus A. [3 ]
Versteegh, Michel I. [4 ]
Joosten, Joris J. [5 ]
Lastdrager, Willem [6 ]
Smit, Egbert F. [7 ]
Slotman, Ben J. [1 ]
Nuyttens, Joost J. M. E. [8 ]
Senan, Suresh [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Radiat Oncol, De Boelelaan 1117,Postbox 7057, NL-1007 MB Amsterdam, Netherlands
[2] Erasmus MC, Dept Cardiothorac Surg, Rotterdam, Netherlands
[3] Vrije Univ Amsterdam, Dept Cardiothorac Surg, Med Ctr Amsterdam, Amsterdam, Netherlands
[4] Leiden Univ, Dept Cardiothorac Surg, Med Ctr, Leiden, Netherlands
[5] Westfriesgasthuis Hoorn, Dept Surg, Hoorn, Netherlands
[6] Gelre Hosp Apeldoorn, Dept Surg, Apeldoorn, Netherlands
[7] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands
[8] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands
来源
RADIATION ONCOLOGY | 2016年 / 11卷
关键词
BODY RADIOTHERAPY; FOLLOW-UP; SURGICAL COMPLICATIONS; CT SCANS; RECURRENCE; OUTCOMES; CLASSIFICATION; MANAGEMENT; DIAGNOSIS; PATTERNS;
D O I
10.1186/s13014-016-0706-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: The literature on surgical salvage, i.e. lung resections in patients who develop a local recurrence following stereotactic ablative radiotherapy (SABR), is limited. We describe our experience with salvage surgery in nine patients who developed a local recurrence following SABR for early stage non-small cell lung cancer (NSCLC). Methods: Patients who underwent surgical salvage for a local recurrence following SABR for NSCLC were identified from two Dutch institutional databases. Complications were scored using the Dindo-Clavien-classification. Results: Nine patients who underwent surgery for a local recurrence were identified. Median time to local recurrence was 22 months. Recurrences were diagnosed with CT- and/or 18FDG-PET-imaging, with four patients also having a pre-surgical pathological diagnosis. Extensive adhesions were observed during two resections, requiring conversion from a thoracoscopic procedure to thoracotomy during one of these procedures. Three patients experienced complications post-surgery; grade 2 (N = 2) and grade 3a (N = 1), respectively. All resection specimens showed viable tumor cells. Median length of hospital stay was 8 days (range 5-15 days) and 30-day mortality was 0 %. Lymph node dissection revealed mediastinal metastases in 3 patients, all of whom received adjuvant therapy. Conclusions: Our experience with nine surgical procedures for local recurrences post-SABR revealed two grade IIIa complications, and a 30-day mortality of 0 %, suggesting that salvage surgery can be safely performed after SABR.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Quality of Life after Stereotactic Body Radiotherapy and Surgery in Patients with Early Stage Non-Small Cell Lung Cancer
    Kastelijn, Elisabeth
    El Sharouni, Sherif
    Hofman, Frederik
    Zanen, Pieter
    Schramel, Franz
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S633 - S634
  • [22] Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy
    Simone, Charles B., II
    Dorsey, Jay F.
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (13)
  • [23] Salvage Surgery for Non-Small Cell Lung Cancer After Definitive Radiotherapy
    Shimizu, Kimihiro
    Ohtaki, Yoichi
    Suzuki, Kenji
    Date, Hiroshi
    Yamashita, Motohiro
    Iizasa, Toshihiko
    Ito, Hiroyuki
    Yoshimura, Kenichi
    Okada, Morihito
    Chida, Masayuki
    ANNALS OF THORACIC SURGERY, 2021, 112 (03): : 862 - 873
  • [24] Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea
    Song, Sanghyuk
    Chang, Ji Hyun
    Kim, Hak Jae
    Kim, Yeon Sil
    Kim, Jin Hee
    Ahn, Yong Chan
    Kim, Jae-Sung
    Song, Si Yeol
    Moon, Sung Ho
    Cho, Moon June
    Youn, Seon Min
    CANCER RESEARCH AND TREATMENT, 2017, 49 (03): : 688 - 694
  • [25] Volume Doubling Times and Outcomes in Stereotactic Ablative Radiotherapy of Early-stage Non-small Cell Lung Cancer
    Chung, M. P.
    Trakul, N.
    Le, Q.
    Hara, W. Y.
    Dieterich, S.
    Maxim, P. G.
    Diehn, M.
    Loo, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S592 - S592
  • [26] Prognostic factors for control of early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
    Charlton, Thomas
    Hindocha, Sumeet
    Hanumanthappa, Nikesh
    Smith, Daniel
    Vivekanandan, Sindu
    Taylor, Benjamin
    Skwarski, Michael
    Ahmad, Shahreen
    LUNG CANCER, 2021, 156 : S60 - S61
  • [27] Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early Stage Non-Small Cell Lung Cancer
    Jacobs, C.
    Gao, J.
    Wang, X.
    Mehta, K.
    Salama, J.
    Torok, J.
    Kelsey, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S611 - S612
  • [28] Stereotactic ablative radiotherapy as single treatment for early stage non-small cell lung cancer: A single institution analysis
    Zheng, Xiaoli
    Sun, Yanan
    Ye, Ke
    Fan, Chengcheng
    Wang, Xiaohui
    Yang, Yang
    Jiao, Ruidi
    Ge, Hong
    THORACIC CANCER, 2021, 12 (06) : 899 - 905
  • [29] Pros: After stereotactic ablative radiotherapy for a peripheral early-stage non-small cell lung cancer, radiological suspicion of a local recurrence can be sufficient indication to proceed to salvage therapy
    Nguyen, Timothy K.
    Palma, David A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (06) : 647 - 650
  • [30] Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer: Rationale and Outcomes
    Iyengar, Puneeth
    Timmerman, Robert D.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (12): : 1514 - 1520